PubRank

L Drouet

Author PubWeight™ 76.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995 1.86
2 Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 2002 1.65
3 Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990 1.53
4 Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991 1.51
5 Embolic and bleeding events after modified Bentall procedure in selected patients. Heart 2006 1.47
6 Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers. Endoscopy 2013 1.46
7 Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997 1.42
8 Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001 1.29
9 Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol 2002 1.19
10 Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol 1981 1.15
11 Renal vascular lesions in lupus nephritis. Medicine (Baltimore) 1997 1.14
12 Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995 1.09
13 Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol 1997 1.09
14 Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis 1987 1.09
15 Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate. Am J Respir Crit Care Med 1998 1.07
16 Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 1990 1.07
17 High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 2000 1.07
18 [Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc 2010 0.96
19 Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2005 0.96
20 In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs. Arterioscler Thromb Vasc Biol 1999 0.96
21 Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr 1987 0.95
22 Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res 1996 0.95
23 Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke. Cerebrovasc Dis 2009 0.92
24 No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 2003 0.92
25 A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost 2010 0.91
26 Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 2002 0.90
27 Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol 1989 0.89
28 Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice. J Pharmacol Exp Ther 2006 0.87
29 A new quantitative D-dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis. Thromb Res 1998 0.86
30 Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 2009 0.86
31 A simple and efficient method for isolating high molecular weight DNA from mammalian sperm. Nucleic Acids Res 1988 0.86
32 Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br J Nutr 1995 0.86
33 Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J Dairy Sci 1993 0.85
34 Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol 2005 0.84
35 Feasibility and reliability of ankle/arm blood pressure index in preventive medicine. Angiology 2000 0.83
36 Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coagul Fibrinolysis 1995 0.83
37 Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. Am J Pathol 1991 0.83
38 Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2013 0.83
39 Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation. Transplantation 1999 0.82
40 Human mesothelial cells express tissue factor when switched to proliferating state. Pharmacological modulation in vitro. Blood Coagul Fibrinolysis 2001 0.82
41 Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig. Exp Hematol 1998 0.82
42 Occurrence of Vitamin Bc Conjugase in Human Plasma. Science 1949 0.81
43 Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude. Thromb Res 1999 0.81
44 Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet alpha-granules from porcine von Willebrand disease. Blood 1986 0.81
45 [Kasabach-Merritt syndrome on a congenital tufted angioma]. Ann Dermatol Venereol 1998 0.81
46 Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors. J Pediatr 1986 0.80
47 Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease. Blood Coagul Fibrinolysis 1998 0.80
48 Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics? Haemostasis 1996 0.80
49 Cutaneous and plasma values of von Willebrand factor in AIDS: a marker of endothelial stimulation? J Invest Dermatol 1988 0.79
50 Usefulness and limitations of animal models of venous thrombosis. Thromb Haemost 2001 0.79
51 Usefulness of 51chromium-platelet labelling for the measurement of platelet deposition on subendothelium. Microvasc Res 1976 0.79
52 [rFVIIa administration in patient with a left ventricular assistance patient]. Ann Fr Anesth Reanim 2005 0.78
53 Endothelial fibrinolytic reactivity and the risk of deep venous thrombosis after spinal cord injury. Spinal Cord 1997 0.78
54 An experimental model for testing von Willebrand factor function: successful SLA-matched crossed bone marrow transplantations between normal and von Willebrand pigs. Exp Hematol 1996 0.78
55 Monitoring of patients with deep-vein thrombosis during and after anticoagulation with D-dimer. Lancet 1998 0.78
56 Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thromb Res 1996 0.78
57 Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost 1996 0.78
58 In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells. J Cardiovasc Pharmacol 1989 0.78
59 Macro and microheterogeneity in normal endothelial cells: differential composition of luminal glycocalyx and functional implications. Endothelium 1999 0.78
60 Nonviral gene transfer into primary cultures of human and porcine mesothelial cells. In Vitro Cell Dev Biol Anim 2001 0.78
61 Lack of association between thrombosis in primary antiphospholipid syndrome and the recently described thrombophilic 3'-untranslated prothrombin gene polymorphism. Thromb Haemost 1997 0.77
62 Time course of plasma growth hormone during exercise in humans at altitude. J Appl Physiol Respir Environ Exerc Physiol 1981 0.77
63 Monoamine oxidase activity in the cerebral vasculature: comparison between fresh microvessels from different structures and cell cultures derived from microvessels. J Cereb Blood Flow Metab 1984 0.77
64 Electrocardiographic observations in high altitude residents of Nepal and Bolivia. Int J Biometeorol 1981 0.77
65 Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide. Br J Haematol 1999 0.77
66 Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. Haemostasis 1992 0.77
67 Oral antiplatelet agents in ACS: from pharmacology to clinical differences. Fundam Clin Pharmacol 2010 0.77
68 Binding of heparin to human endothelial cell monolayer and extracellular matrix in culture. Thromb Res 1987 0.77
69 Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis. Thromb Res 1983 0.77
70 Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells. Endothelium 1997 0.77
71 Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young. Stroke 1997 0.77
72 Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe. Blood 1988 0.77
73 D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation. Thromb Res 2002 0.76
74 Inverse immunostaining pattern for synthesized versus endocytosed alpha-granule proteins in human bone marrow megakaryocytes. Br J Haematol 1998 0.76
75 Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease. Nouv Rev Fr Hematol 1993 0.76
76 Recombinant von Willebrand factor. Thromb Haemost 1997 0.76
77 Thrombosis, platelet behaviour, fibrinolytic activity, and diet on the Andes plateau. Haemostasis 1974 0.76
78 [Congenital deficiency of platelet alpha-granules and medullary reticulinic fibrosis. Physiopathogenic hypothesis (author's transl)]. Nouv Rev Fr Hematol 1981 0.76
79 Lack of association between ADH3 polymorphism, alcohol intake, risk factors and carotid intima-media thickness. Atherosclerosis 2005 0.76
80 Erythrocyte hyperaggregation and thrombogenic dysfibrinogenemia. Clin Hemorheol Microcirc 1998 0.76
81 Diffuse severe digestive angiodysplasia in Bernard-Soulier syndrome. Improvement of bleeding by oestroprogestative therapy. Thromb Haemost 1995 0.76
82 Clopidogrel-induced qualitative changes in thrombus formation correlate with stent patency in injured pig cervical arteries. Thromb Res 2002 0.76
83 [Four years of circulatory support with the INCOR axial pump from Berlin Heart]. Arch Mal Coeur Vaiss 2007 0.76
84 [Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas]. Ann Dermatol Venereol 1998 0.76
85 Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis. J Thromb Haemost 2004 0.75
86 Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis. J Intern Med 2013 0.75
87 How does ticlopidine treatment lower plasma fibrinogen? Thromb Res 1994 0.75
88 [PDGF (platelet derived growth factor): a regulator of connective tissue proliferation or an artefact?]. Nouv Rev Fr Hematol 1982 0.75
89 Importance of transport mechanisms in circulating blood for platelet deposition on arterial subendothelium. Microvasc Res 1977 0.75
90 [Ticlid]. Soins 1985 0.75
91 Splanchnic blood flow, O2 consumption, removal of lactate, and output of glucose in highlanders. J Appl Physiol Respir Environ Exerc Physiol 1977 0.75
92 [Anti-JKa specificity : a rare variety of auto-immune hemolytic anemia (report of a case associated with myxoedema (author's transl)]. Sem Hop 1982 0.75
93 [Is aspirin resistance a reality?]. Rev Med Interne 2004 0.75
94 [Anti-thrombotic effect of lacto-transferrin peptides]. C R Seances Soc Biol Fil 1990 0.75
95 [Blood platelets and vascular thrombosis]. Soins 1985 0.75
96 Uptake of noradrenaline in high altitude native's heart. Experientia 1977 0.75
97 [Traumatic left ventricular aneurysm disclosed by systemic emboli. Value of platelet labelling with indium]. Ann Med Interne (Paris) 1984 0.75
98 Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin. Thromb Res 1984 0.75
99 [Monitoring of anticoagulant treatment in patients with cancer]. Pathol Biol (Paris) 2008 0.75
100 [What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?]. Arch Mal Coeur Vaiss 1996 0.75
101 [Relation between the wall structure and modifications of the blood content (author's transl)]. J Mal Vasc 1981 0.75
102 Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudin. Thromb Res 2002 0.75
103 Molecular weight and shape of angiotensin-I converting enzyme. A neutron scattering study. Biochem Biophys Res Commun 1988 0.75
104 The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis. Thromb Haemost 1996 0.75
105 Major plasma cells' dystrophy in monoclonal gammopathy of undeterminated significance. Eur J Haematol 2012 0.75
106 [Hemostasis tests as markers of hepatic and endothelial toxicity in chemotherapy]. Nouv Rev Fr Hematol 1988 0.75
107 Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries. Thromb Haemost 1995 0.75
108 [Incidence of biological intravascular coagulation in legal induced abortions]. Ann Fr Anesth Reanim 1986 0.75
109 [Pure defibrination after timber rattlesnake bite]. Presse Med 1983 0.75
110 G20210A prothrombin gene mutation in two siblings with cerebral venous thrombosis. Neurology 1998 0.75
111 [Interaction between the platelets and the vessel wall. Part 3: Investigation]. Nouv Presse Med 1980 0.75
112 In vitro synthesis of DNA, protein, and lipids by the de-endothelialized rabbit aorta. Arteriosclerosis 1982 0.75
113 Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels. J Thromb Haemost 2010 0.75
114 [Update on the use of estramustin in metastatic prostate cancer]. Prog Urol 2009 0.75
115 Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 1989 0.75
116 [Comparison of the effects of ketorolac and aspirin on hemostasis in the rabbit]. Ann Fr Anesth Reanim 1995 0.75
117 [Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig]. Dakar Med 1999 0.75
118 [Evaluation of hemostasis in thrombotic pathology? A critical study apropos of 200 records]. Presse Med 1983 0.75
119 French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time. Thromb Haemost 1994 0.75
120 [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)]. Nouv Presse Med 1980 0.75
121 [Willebrand syndrome acquired during an amylosis of primitive appearance]. Nouv Rev Fr Hematol 1984 0.75
122 [Muscular blood flow in human highlanders and in lowlanders living at altitude (3 800 m) (author's transl)]. J Physiol (Paris) 1975 0.75
123 [What model for which thrombosis and why?]. Vasa Suppl 1989 0.75
124 Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation. Nouv Rev Fr Hematol 1990 0.75
125 Absence of incorporation of plasma von Willebrand factor into porcine platelet alpha-granules. Br J Haematol 1995 0.75
126 [Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse]. Presse Med 1995 0.75
127 [Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]. Rev Mal Respir 2008 0.75
128 Phenotypic and functional characteristics of porcine peritoneal mesothelial cells. In Vitro Cell Dev Biol Anim 2000 0.75
129 [Interactions between the platelets and the vessel wall. Part 2: physiopathology (author's transl)]. Nouv Presse Med 1980 0.75
130 Purification and analysis of lung and plasma angiotensin I-converting enzyme by high-performance liquid chromatography. Protein Expr Purif 1992 0.75
131 [Pregnancy follow-up and outcome in women with superficial vascular malformations]. Gynecol Obstet Fertil 2010 0.75
132 [Blood activation during long-term mechanical circulatory support]. Pathol Biol (Paris) 2005 0.75
133 Characterization of a thrombopathy (type delta storage pool disease) affecting a pig colony. Nouv Rev Fr Hematol 1992 0.75
134 [Molecular abnormalities in recurrent thromboembolic disease]. Presse Med 1983 0.75
135 [Thrombocytopenia induced by heparin. Diagnosis, treatment, physiopathology: current concepts]. Ann Med Interne (Paris) 1986 0.75
136 [Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor]. Dakar Med 1999 0.75
137 Weibel-Palade bodies in pig megakaryocytes. Biol Struct Morphog 1988 0.75
138 [Plasmodium falciparum malaria acquired in France (author's transl)]. Nouv Presse Med 1980 0.75
139 [Hemorrhagic rectocolitis associated with idiopathic thrombopenic purpura]. Gastroenterol Clin Biol 1985 0.75